These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12673388)

  • 21. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
    O'Donnell RA; Saul A; Cowman AF; Crabb BS
    Nat Med; 2000 Jan; 6(1):91-5. PubMed ID: 10613831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary study of a recombinant polyvalent vaccine of Plasmodium falciparum and its immunological activity].
    Li Q; Li Y; Xie Y
    Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):325-8, 381. PubMed ID: 7553140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.
    Faber BW; Remarque EJ; Morgan WD; Kocken CH; Holder AA; Thomas AW
    Infect Immun; 2007 Dec; 75(12):5947-55. PubMed ID: 17938224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.
    Stowers AW; Chen Lh LH; Zhang Y; Kennedy MC; Zou L; Lambert L; Rice TJ; Kaslow DC; Saul A; Long CA; Meade H; Miller LH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):339-44. PubMed ID: 11752405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium falciparum: IgG subclass antibody response to merozoite surface protein-1 among Amazonian gold miners, in relation to infection status and disease expression.
    Scopel KK; Fontes CJ; Ferreira MU; Braga EM
    Exp Parasitol; 2005 Feb; 109(2):124-34. PubMed ID: 15687019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1.
    Tetteh KK; Conway DJ
    Vaccine; 2011 Oct; 29(44):7811-7. PubMed ID: 21820475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village.
    Perraut R; Marrama L; Diouf B; Sokhna C; Tall A; Nabeth P; Trape JF; Longacre S; Mercereau-Puijalon O
    J Infect Dis; 2005 Jan; 191(2):264-71. PubMed ID: 15609237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
    Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
    Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
    Stoute JA; Gombe J; Withers MR; Siangla J; McKinney D; Onyango M; Cummings JF; Milman J; Tucker K; Soisson L; Stewart VA; Lyon JA; Angov E; Leach A; Cohen J; Kester KE; Ockenhouse CF; Holland CA; Diggs CL; Wittes J; Heppner DG;
    Vaccine; 2007 Jan; 25(1):176-84. PubMed ID: 16388879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1.
    James S; Moehle K; Renard A; Mueller MS; Vogel D; Zurbriggen R; Pluschke G; Robinson JA
    Chembiochem; 2006 Dec; 7(12):1943-50. PubMed ID: 17068840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibodies specific to Plasmodium falciparum antigens in immune individuals: III. Seasonal course of the response to a major antigen of the asexual blood forms in two sites of different malaria exposure].
    Diallo TO; Nguer CM; Tall A; Diouf A; Spiegel A; Perraut R; Garraud O
    Dakar Med; 1999; 44(1):63-8. PubMed ID: 10797990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.
    Singh S; Kennedy MC; Long CA; Saul AJ; Miller LH; Stowers AW
    Infect Immun; 2003 Dec; 71(12):6766-74. PubMed ID: 14638762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.
    Li C; Wang R; Wu Y; Zhang D; He Z; Pan W
    Malar J; 2010 Apr; 9():94. PubMed ID: 20384992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-sectional study of specific antibodies to a polymorphic Plasmodium falciparum antigen and of parasite antigen genotypes in school children on the slope of Mount Cameroon.
    Kimbi HK; Tetteh KK; Polley SD; Conway DJ
    Trans R Soc Trop Med Hyg; 2004 May; 98(5):284-9. PubMed ID: 15109551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
    Nurul AA; Norazmi MN
    Parasitol Res; 2011 Apr; 108(4):887-97. PubMed ID: 21057812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
    Cao Y; Zhang DM; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phagocytic activity and pro-inflammatory cytokines production by the murine macrophage cell line J774A.1 stimulated by a recombinant BCG (rBCG) expressing the MSP1-C of Plasmodium falciparum.
    Rapeah S; Dhaniah M; Nurul AA; Norazmi MN
    Trop Biomed; 2010 Dec; 27(3):461-9. PubMed ID: 21399587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and evaluation of a multistage combination vaccine against malaria.
    Zhang Q; Xue X; Qu L; Pan W
    Vaccine; 2007 Mar; 25(11):2112-9. PubMed ID: 17241708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals.
    Zhang Q; Xue X; Xu X; Wang C; Chang W; Pan W
    J Clin Immunol; 2009 Jul; 29(4):454-60. PubMed ID: 19247821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.